Astrana Health (ASTH) Short term Debt (2012 - 2026)

Astrana Health has disclosed Short term Debt across 14 years of filings, most recently posting $47.9 million for Q1 2026.

• Short term Debt for Q1 2026 came in at $47.9 million, up 282.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $47.9 million (up 282.92% YoY), and the FY2025 annual result was $47.9 million, up 410.56% from the prior year.
• Short term Debt came in at $47.9 million for Q1 2026 at Astrana Health, roughly flat from $47.9 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $47.9 million in Q3 2025 to a low of $619000.0 in Q4 2022.
• The 5-year median for Short term Debt is $12.5 million (2025), against an average of $15.5 million.
• Across the five-year window, Short term Debt slumped 87.56% in 2022 and surged 3241.38% in 2024, its largest moves.
• Astrana Health's Short term Debt stood at $619000.0 in 2022, then jumped by 3050.24% to $19.5 million in 2023, then sank by 51.92% to $9.4 million in 2024, then surged by 410.56% to $47.9 million in 2025, then changed by 0.0% to $47.9 million in 2026.
• The last three Short term Debt figures came in at $47.9 million (Q1 2026), $47.9 million (Q4 2025), and $47.9 million (Q3 2025), per Business Quant data.